On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

An investigational cell therapy being evaluated at UC Davis Health has been granted fast-track designation by the U.S. Food and Drug Administration to help patients with oropharyngeal dysphagia ...

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...

One concern with in vivo CAR-Ts is the potential insertional mutagenesis of the lentiviral DNA payload, causing secondary ...

A Houston gym owner and fitness instructor struggled with severe neck and back pain. Traditional treatments failed, leading her to stem cell therapy using umbilical cord cells.

Lizard venom has played a crucial part in helping humans take a bite out of diabetes and obesity. The Gila monster is a large, magnificent and venomous desert-dwelling reptile found throughout the ...

The US Food and Drug Administration (FDA) has approved bevacizumab-nwgd (Jobevne, Biocon Biologics Ltd), a biosimilar to bevacizumab (Avastin, Genentech), for intravenous use across multiple cancer ...

Concurrently, the FDA also granted XellSmart a special exemption to support the clinical trial of XellSmart's cell therapy for PD in the US. The approval of XellSmart's clinical trial, along with ...

Fate Therapeutics (FATE) announced that the U.S. Food and Drug Administration, FDA, granted Regenerative Medicine Advanced Therapy, RMAT, ...